Ligand increases base salary and target bonus for President/COO and CFO

LIGAND PHARMACEUTICALS INC

Matthew Korenberg (President & COO) base salary set at $540,000 with 50% target bonus.
Octavio Espinoza (CFO) base salary set at $400,000 with 40% target bonus.
Changes effective December 5, 2022, tied to recent promotions to these roles.

item 5.02

LIGAND PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0000886163-22-000140

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.